Dietary supplementation with 22-S-hydroxycholesterol to rats reduces body weight gain and the accumulation of liver triacylglycerol

Lipids

Volumn 47, Issue 5, 2012, Pages 483-493

  Kase, Eili Tranheim ^a   Nikolić, Nataša ^a   Hessvik, Nina Pettersen ^a   Fjeldheim, Åse Karine ^a   Jensen, Jørgen ^b,c   Hege Thoresen, G ^a   Rustan, Arild C ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN SCHOOL OF SPORT SCIENCES   (Norway)

^c NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

Author keywords

22 S hydroxycholesterol; In vivo; LXR; Ucp3

Indexed keywords

22 HYDROXYCHOLESTEROL; GLUCOSE; MESSENGER RNA; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CARNITINE PALMITOYLTRANSFERASE 2 GENE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EXCRETION; DRUG FECES LEVEL; DRUG HALF LIFE; DRUG MECHANISM; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GLUCOSE METABOLISM; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPID STORAGE; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; RNA SEQUENCE; SEQUENCE ANALYSIS; TIME TO MAXIMUM PLASMA CONCENTRATION; TRIACYLGLYCEROL BLOOD LEVEL; UNCOUPLING PROTEIN 3 GENE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; DIETARY SUPPLEMENTS; FATTY ACIDS; HYDROXYCHOLESTEROLS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 84863436894     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3663-4     Document Type: Article

References (30)

1. Geyeregger R, Zeyda M, Stulnig TM (2006) Liver X receptors in cardiovascular and metabolic disease. Cell Mol Life Sci 63:524-539
2. Kase ET, Wensaas AJ, Aas V et al (2005) Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes 54:1108-1115 (Pubitemid 40446325)
3. Schultz JR, Tu H, Luk A et al (2000) Role of LXRs in control of lipogenesis. Genes Dev 14:2831-2838
4. Kase ET, Andersen B, Nebb HI, Rustan AC, Thoresen GH (2006) 22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes. Biochim Biophys Acta 1761:1515-1522 (Pubitemid 44822667)
5. Kase ET, Thoresen GH, Westerlund S et al (2007) Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals. Diabetologia 50:2171-2180 (Pubitemid 47373846)
6. Hessvik NP, Bakke SS, Smith R et al (2012) The liver X receptor modulator 22 (S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism. J Steroid Biochem Mol Biol 128:154-164
7. Janowski BA, Grogan MJ, Jones SA et al (1999) Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 96:266-271 (Pubitemid 29036088)
8. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ (1996) An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 383:728-731 (Pubitemid 26360651)
9. Spencer TA, Li D, Russel JS et al (2001) Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha. J Med Chem 44:886-897 (Pubitemid 32861613)
10. Svensson S, Ostberg T, Jacobsson M et al (2003) Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation. EMBO J 22:4625-4633 (Pubitemid 37162899)
11. Fu X, Menke JG, Chen Y et al (2001) 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 276:38378-38387
12. Forman BM, Ruan B, Chen J, Schroepfer GJ Jr, Evans RM (1997) The orphan nuclear receptor LXRalpha is positively and negatively regulated by distinct products of mevalonate metabolism. Proc Natl Acad Sci USA 94:10588-10593
13. Mitro N, Mak PA, Vargas L et al (2007) The nuclear receptor LXR is a glucose sensor. Nature 445:219-223 (Pubitemid 46095727)
14. Franch J, Aslesen R, Jensen J (1999) Regulation of glycogen synthesis in rat skeletal muscle after glycogen-depleting contractile activity: effects of adrenaline on glycogen synthesis and activation of glycogen synthase and glycogen phosphorylase. Biochem J 344(Pt 1):231-235
15. Aslesen R, Jensen J (1998) Effects of epinephrine on glucose metabolism in contracting rat skeletal muscles. Am J Physiol 275:E448-E456
16. Kelly OM, McNamara YM, Manzke LH, Meegan MJ, Porter RK (2012) The preservation of in vivo phosphorylated and activated uncoupling protein 3 (UCP3) in isolated skeletal muscle mitochondria following administration of 3, 4-methylenedioxymethamphetamine (MDMA aka ecstasy) to rats/mice. Mitochondrion 12:110-119
17. Bezaire V, Seifert EL, Harper ME (2007) Uncoupling protein-3: clues in an ongoing mitochondrial mystery. Faseb J 21:312-324 (Pubitemid 46213479)
18. Samec S, Seydoux J, Dulloo AG (1998) Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? Faseb J 12:715-724 (Pubitemid 28247150)
19. Hwang CS, Lane MD (1999) Up-regulation of uncoupling protein-3 by fatty acid in C2C12 myotubes. Biochem Biophys Res Commun 258:464-469 (Pubitemid 29287074)
20. Brun S, Carmona MC, Mampel T et al (1999) Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: apotential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes 48:1217-1222 (Pubitemid 29241017)
21. Moore GB, Himms-Hagen J, Harper ME, Clapham JC (2001) Overexpression of UCP-3 in skeletal muscle of mice results in increased expression of mitochondrial thioesterase mRNA. Biochem Biophys Res Commun 283:785-790 (Pubitemid 32924648)
22. Choi CS, Fillmore JJ, Kim JK et al (2007) Overexpression of uncoupling protein 3 in skeletal muscle protects against fatinduced insulin resistance. J Clin Invest 117:1995-2003 (Pubitemid 47036334)
23. Chow L, From A, Seaquist E (2010) Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction. Metabolism 59:70-85
24. Lara-Castro C, Garvey WT (2008) Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am 37:841-856
25. Szendroedi J, Roden M (2009) Ectopic lipids and organ function. Curr Opin Lipidol 20:50-56
26. Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
27. Changani KK, Nicholson A, White A et al (2003) A longitudinal magnetic resonance imaging (MRI) study of differences in abdominal fat distribution between normal mice, and lean overexpressors of mitochondrial uncoupling protein-3 (UCP-3). Diabetes Obes Metab 5:99-105 (Pubitemid 36372501)
28. Senese R, Valli V, Moreno M et al (2011) Uncoupling protein 3 expression levels influence insulin sensitivity, fatty acid oxidation, and related signaling pathways. Pflugers Arch 461:153-164
29. Clapham JC, Coulthard VH, Moore GB (2001) Concordant mRNA expression of UCP-3, but not UCP-2, with mitochondrial thioesterase-1 in brown adipose tissue and skeletal muscle in db/db diabetic mice. Biochem Biophys Res Commun 287:1058-1062 (Pubitemid 32980558)
30. Costford SR, Chaudhry SN, Salkhordeh M, Harper ME (2006) Effects of the presence, absence, and overexpression of uncoupling protein-3 on adiposity and fuel metabolism in congenic mice. Am J Physiol Endocrinol Metab 290:E1304-E1312 (Pubitemid 43847916)